CNS Pharma

PriceCNS Pharma

CNSP

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Historical stock price chart and annual return over the past years

-100%

5 years

% Total

CNSP
-91%

5 years

Annual Return

CNSP